SCHEMBL669444

SCHEMBL669444

O=C(O)C(Cc1c[nH]cn1)NO

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CPB2 Q96IY4 6/20 0.34
CPB1 P15086 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL669445 1.00 CPB2 (0.34) CPB2CPB1SMN1; SMN2
SCHEMBL3378638 0.87 CPB2 (0.34) CPB2CPB1SMN1; SMN2
SCHEMBL3378642 0.87 CPB2 (0.34) CPB2CPB1SMN1; SMN2
Hydrochloric Acid SCHEMBL30634622 0.87 CPB2 (0.34) CPB2CPB1SMN1; SMN2
SCHEMBL6887981 0.85 CPB2 (0.33) CPB2CPB1SMN1; SMN2
SCHEMBL4292047 0.85 CPB2 (0.33) CPB2CPB1SMN1; SMN2
SCHEMBL1666636 0.85 CPB2 (0.36) CPB2CPB1SMN1; SMN2
SCHEMBL1073717 0.85 ITGB2 (0.36) CPB2CPB1
SCHEMBL163396 0.85 CPB2 (0.36) CPB2CPB1SMN1; SMN2
SCHEMBL151334 0.85 CPB2 (0.36) CPB2CPB1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 302 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250122239-A1 DUAL AGONIST GLP-1 AND NEUROTENSIN FUSION PEPTIDE HOLST BIRGITTE (DK) 2025-04-17 US claimed
EP-3891176-B1 DUAL AGONIST GLP-1 AND NEUROTENSIN FUSION PEPTIDE HOLST BIRGITTE (DK) 2024-06-05 EP claimed
CN-117797784-A Preparation process and application of surface modified porous titanium dioxide 河南龙兴钛业科技股份有限公司 2024-04-02 CN claimed
CN-117778530-A Method for adding preset joint to 5' end of single-stranded DNA 清华大学 2024-03-29 CN claimed
CN-114479874-B Red mud-based heavy metal curing agent and preparation method and application thereof 山东大学 2023-05-16 CN claimed
CN-112043835-B Bioreversible introducing group for nitrogen and hydroxyl-containing drugs 韩捷 2022-10-21 CN claimed
CN-114479874-A Red mud-based heavy metal curing agent and preparation method and application thereof 山东大学 2022-05-13 CN claimed
US-20220056077-A1 DUAL AGONIST GLP-1 AND NEUROTENSIN FUSION PEPTIDE RATNER, Cecilia (DK) 2022-02-24 US claimed
EP-3891176-A1 DUAL AGONIST GLP-1 AND NEUROTENSIN FUSION PEPTIDE Københavns Universitet (DK) 2021-10-13 EP claimed
CN-112142855-A Protein for diabetes treatment, protein conjugate and application thereof 爱德迪安(北京)生物技术有限公司 2020-12-29 CN claimed
EP-1704165-A1 NOVEL GLP-1 COMPOUNDS NOVO NORDISK A/S (DK) 2006-09-27 EP claimed
JP-2006520818-A 2006-09-14 JP claimed
EP-1696962-A2 NOVEL GLP-1 ANALOGUES LINKED TO ALBUMIN-LIKE AGENTS NOVO NORDISK A/S (DK) 2006-09-06 EP claimed
EP-1605897-A2 POLYETHELENE GLYCOL LINK GLP-1 COMPOUNDS ELI LILLY AND COMPANY (US) 2005-12-21 EP claimed
WO-2005058954-A1 NOVEL GLP-1 COMPOUNDS NOVO NORDISK A/S (DK) 2005-06-30 WO claimed
WO-2005058958-A2 NOVEL GLP-1 ANALOGUES LINKED TO ALBUMIN-LIKE AGENTS NOVO NORDISK A/S (DK) 2005-06-30 WO claimed
WO-2004093823-A2 POLYETHELENE GLYCOL LINK GLP-1 COMPOUNDS ELI LILLY AND COMPANY (US) 2004-11-04 WO claimed
CN-1040328-C Complex salts of hematoporphyrin and of its derivatives, their synthesis, and therapeutic agent WUJSKOWA AKADEMIA TECHNICZNA I (PL) 1998-10-21 CN claimed
WO-1998043658-A1 GLUCAGON-LIKE PEPTIDE-1 ANALOGS ELI LILLY AND COMPANY (US) 1998-10-08 WO claimed
CN-1071914-A The composite salt of haematoporphyrin and its derivative, they synthetic and be used as therapeutical agent WOJSKOWA AKAD TECH (PL) 1993-05-12 CN claimed